Christine Cassiano | Chief Communications Officer |
David Chang | President & Chief Executive Officer |
Zachary Roberts | Executive Vice President-Research and Development & Chief Medical Officer |
Eric Schmidt | Chief Financial Officer |
Tyler Van Baron | TD Cowen |
Michael Yee | Jefferies |
Brian Cheng | JPMorgan |
Kelsey Goodwin | Guggenheim |
John Newman | Canaccord |
Jack Allen | Baird |
Kalpit Patel | B. Riley |
Sami Corwin | William Blair |
Luca Issi | RBC Capital |
Tony Butler | EF Hutton |
Akash Singh | Oppenheimer |
Reni Benjamin | JMP Securities |
Jason Gerberry | Bank of America Securities |
William Pickering | Bernstein |
Carolina Ibanez Ventoso | Stifel |
Hello. Thank you for standing by, and welcome to Allogene Therapeutics Second Quarter 2023 Conference Call. After the speaker's presentation, there will be a question-and-answer session. [Operator Instructions] Please be aware that today's conference is being recorded.
I would now like to turn the call over to Christine Cassiano, Chief Communications Officer.